Elanco wins conditional EU antitrust okay for $7.6 billion Bayer deal

Elanco Animal Health secured EU antitrust clearance on Monday to buy Bayer’s veterinary drugs unit after pledging to sell some products to address competition concerns about the $7.6 billion deal.